What is the expected growth forecast for the Automated Cell Processing Systems for Cell Therapy market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Automated Cell Processing Systems for Cell Therapy market?

Increasing demand for cell therapy and advancements in automation technology are key drivers.

Which regions are leaders in the Automated Cell Processing Systems for Cell Therapy market?

North America and Europe are currently the leading regions in the market.

Who are the top companies in the Automated Cell Processing Systems for Cell Therapy market?

Leading companies include Beckman Coulter and Terumo BCT.

What future opportunities exist in the Automated Cell Processing Systems for Cell Therapy market?

Emerging markets and increasing adoption of cell therapy treatments offer future opportunities.

What is the current regulatory landscape for the Automated Cell Processing Systems for Cell Therapy market?

Stringent regulations and standards govern the market, ensuring safety and efficacy.

What is the future outlook for the Automated Cell Processing Systems for Cell Therapy market?

The market is expected to experience significant growth, driven by increasing demand for cell therapy.

Automated Cell Processing Systems for Cell Therapy Growth, Trends & Forecast Outlook 2033

Automated Cell Processing Systems for Cell Therapy by Application (Academia, Industrial), by Types (Stem Cell Therapy, Non-Stem Cell Therapy), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 136

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 136

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Automated Cell Processing Systems for Cell Therapy Market Overview

The Automated Cell Processing Systems for Cell Therapy market is a rapidly evolving segment that enables the efficient processing of cells for therapeutic applications. As the cell therapy industry continues to expand, the demand for automated cell processing systems is on the rise, driving the Automated Cell Processing Systems for Cell Therapy market size to reach approximately $1.4 billion by 2025. The growth outlook for this market is promising, with a projected market forecast of $4.8 billion by 2033, indicating a compound annual growth rate (CAGR) of 14.5%. The industry expansion is expected to be driven by advances in technology, increasing adoption of cell therapies, and rising investments in research and development.

Loading chart…

The Automated Cell Processing Systems for Cell Therapy market is being shaped by several key forces, including technology shifts towards closed systems, regulations supporting the adoption of automated systems, and competitive intensity driven by the entry of new players. The largest region in this market is currently North America, while the fastest-growing region is expected to be Asia-Pacific. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to remain competitive. The growth forecast indicates a positive outlook, with the market expected to be driven by increasing demand for cell therapies and advancements in automation technologies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cytiva; Miltenyi Biotec; Thermo Fisher Scientific; Terumo; Merck; Fresenius Kabi; Sartorius; Lonza; Boyalife (ThermoGenesis); EurekaBio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Automated Cell Processing Systems for Cell Therapy market is poised for significant growth, driven by increasing demand for cell therapies and advancements in automation technology. The Automated Cell Processing Systems for Cell Therapy market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in automation technology have improved the efficiency and consistency of cell processing, reducing the risk of human error and increasing the scalability of cell therapy production. This has driven the adoption of Automated Cell Processing Systems for Cell Therapy, contributing to market growth.

The rising demand for cell therapies, particularly in the treatment of cancer and genetic disorders, has created a need for automated cell processing systems that can handle large volumes of cells while maintaining high levels of quality and purity.

Restraints2 items

High upfront costs and maintenance expenses associated with Automated Cell Processing Systems for Cell Therapy can be a significant barrier to adoption, particularly for small and medium-sized enterprises. This may limit the market growth forecast.

Stringent regulatory requirements and the need for specialized training to operate Automated Cell Processing Systems for Cell Therapy can also hinder market expansion, affecting the overall Automated Cell Processing Systems for Cell Therapy market size.

Opportunities2 items

The increasing focus on personalized medicine has created opportunities for Automated Cell Processing Systems for Cell Therapy to be used in the development of tailored cell therapies, driving market growth and influencing the growth forecast.

The growing demand for regenerative medicine and tissue engineering has also opened up new avenues for Automated Cell Processing Systems for Cell Therapy, contributing to the expansion of the Automated Cell Processing Systems for Cell Therapy market size.

Challenges2 items

Ensuring the quality and consistency of automated cell processing systems is a significant challenge, as it requires rigorous testing and validation to meet regulatory standards, which can impact the Automated Cell Processing Systems for Cell Therapy market size and growth forecast.

The lack of standardization in automated cell processing systems can also create challenges for companies looking to scale up their cell therapy production, affecting the overall growth of the Automated Cell Processing Systems for Cell Therapy market.

Market Segmentation

Loading chart…

The Automated Cell Processing Systems for Cell Therapy segmentation by application is a crucial aspect of understanding the market dynamics. This segment is further divided into subtypes, including cell banking, cell therapy processing, and cell therapy research. Each of these subtypes contributes significantly to the overall market size, with cell banking being the largest contributor due to the increasing demand for stem cell banking and regenerative medicine.

The types segment of the Automated Cell Processing Systems for Cell Therapy market is categorized into closed systems and open systems. Closed systems are further subdivided into automated and semi-automated systems, while open systems are categorized into manual and semi-automated systems. This segmentation is vital in understanding the market taxonomy, as each subtype has its own set of advantages and disadvantages, and caters to different customer needs.

Automated Cell Processing Systems for Cell Therapy Segmentation Breakdown6 items

Application

Academia

Industrial

Types

Stem Cell Therapy

Non-Stem Cell Therapy

Regional Insights

Loading chart…

The Automated Cell Processing Systems for Cell Therapy market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of cell therapy and investments in healthcare infrastructure. Key drivers for North America include policies supporting cell therapy research, a mature ecosystem, and high demographics demand for cell therapy treatments.

In Europe, key drivers include infrastructure development, ecosystem maturity, and increasing adoption of cell therapy. Asia Pacific's growth is driven by investments in healthcare, a large demographics base, and supportive policies. Latin America and Middle East & Africa are expected to experience slower growth due to limited infrastructure and ecosystem maturity, but are still expected to contribute to the regional forecast.

Regional Key Drivers5 items

North America: policies, ecosystem maturity, demographics

Europe: infrastructure, ecosystem maturity, adoption

Asia Pacific: investments, demographics, policies

Latin America: increasing adoption, infrastructure development

Middle East & Africa: growing demographics, investments in healthcare

Competitive Landscape

The Automated Cell Processing Systems for Cell Therapy competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. The market is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolio and strengthening their distribution networks, while local/regional companies are concentrating on regional expansion and customization. Understanding the Automated Cell Processing Systems for Cell Therapy competitive landscape is crucial for companies to develop effective strategies and stay competitive.

Companies in this market are adopting various strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. They are differentiating themselves through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies need to focus on innovation, premium pricing, and strategic partnerships.

Cytiva: regional expansion

Miltenyi Biotec: innovation pipeline

Thermo Fisher Scientific: vertical integration

Terumo: local manufacturing

Merck: premium pricing

Fresenius Kabi: OEM tie-ups

Key Automated Cell Processing Systems for Cell Therapy Companies10 items

Cytiva

Miltenyi Biotec

Thermo Fisher Scientific

Terumo

Merck

Fresenius Kabi

Sartorius

Lonza

Boyalife (ThermoGenesis)

EurekaBio

Market Ecosystem

The Automated Cell Processing Systems for Cell Therapy ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where systems are manufactured and integrated; and downstream, where end users adopt and utilize the systems. Value is created and captured at each stage, with technology providers and suppliers influencing the development of automated cell processing systems, and end users driving demand.

Raw material/component suppliers — provide critical system components

OEMs / manufacturers — design and manufacture automated systems

Technology providers — develop underlying automation technologies

System integrators / EPCs — integrate systems for end-user applications

Distributors / channel partners — facilitate system sales and distribution

Regulators/standards bodies — establish guidelines and approvals

End users / buyers — adopt and utilize automated cell processing systems

In the Automated Cell Processing Systems for Cell Therapy ecosystem, control points are primarily held by regulators and end users, who influence adoption through approvals and demand. Dependency risks arise from input constraints, standards, and approvals, which can impact the supply chain. Switching costs and partnerships are also critical, as they can affect system compatibility and usability. Furthermore, interoperability requirements can vary by region, leading to differences in the ecosystem across diverse areas, highlighting the need for a comprehensive value chain analysis to understand these dynamics.

Recent Industry Insights

The Automated Cell Processing Systems for Cell Therapy industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading biotechnology companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, with major players expanding their portfolios to include automated cell processing systems. Furthermore, several product and technology launches have been announced, enhancing the efficiency and scalability of cell therapy manufacturing processes.

Additionally, regulatory changes have supported the growth of the Automated Cell Processing Systems for Cell Therapy market, with funding rounds and expansions providing necessary resources for research and development. A shift in consumer and enterprise trends has also been observed, with increased focus on personalized medicine and cell-based therapies. As a result, the industry is expected to continue its upward trajectory, driven by advancements in automated cell processing systems and growing demand for cell therapies.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Automated Cell Processing Systems for Cell Therapy market outlook is highly attractive due to its potential to revolutionize cell therapy manufacturing. The market is characterized by high competitive intensity, with several key players investing heavily in research and development. The long-term outlook for this market is positive, driven by increasing demand for cell therapies and the need for efficient, scalable, and cost-effective manufacturing solutions.

The innovation landscape is dynamic, with ongoing advancements in automation, artificial intelligence, and data analytics. However, the demand–supply balance is a key concern, as the market is experiencing shortages of skilled personnel and high-quality raw materials. Key risk factors include regulatory changes, supply chain disruptions, and the need for standardization of cell processing protocols. Overall, the Automated Cell Processing Systems for Cell Therapy market is poised for significant growth, driven by its potential to transform the cell therapy industry.

11 items

1. Executive Summary

2. Automated Cell Processing Systems for Cell Therapy Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Automated Cell Processing Systems for Cell Therapy Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Automated Cell Processing Systems for Cell Therapy Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academia

6.1.2. Industrial

6.2. Global Automated Cell Processing Systems for Cell Therapy Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Stem Cell Therapy

6.2.2. Non-Stem Cell Therapy

6.3. Global Automated Cell Processing Systems for Cell Therapy Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Automated Cell Processing Systems for Cell Therapy Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Automated Cell Processing Systems for Cell Therapy Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Automated Cell Processing Systems for Cell Therapy Market Competition by Key Manufacturers

8.1. Global Automated Cell Processing Systems for Cell Therapy Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Automated Cell Processing Systems for Cell Therapy: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cytiva

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Miltenyi Biotec

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Thermo Fisher Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Merck

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Fresenius Kabi

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sartorius

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Lonza

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Boyalife (ThermoGenesis)

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. EurekaBio

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Automated Cell Processing Systems for Cell Therapy Market

Figure 4: Global Automated Cell Processing Systems for Cell Therapy Market: Drivers

Figure 5: Global Automated Cell Processing Systems for Cell Therapy Market: Challenges

Figure 6: Global Automated Cell Processing Systems for Cell Therapy Market: Trends

Figure 7: Global Automated Cell Processing Systems for Cell Therapy Market: Opportunity

Figure 8: Global Automated Cell Processing Systems for Cell Therapy Market: Restraint

Figure 9: Global Automated Cell Processing Systems for Cell Therapy Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Automated Cell Processing Systems for Cell Therapy Market Value (USD Million) By Region

Figure 15: Global Automated Cell Processing Systems for Cell Therapy Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Automated Cell Processing Systems for Cell Therapy Market Value (USD Million) By Region

Figure 23: Global Automated Cell Processing Systems for Cell Therapy Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Automated Cell Processing Systems for Cell Therapy Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Automated Cell Processing Systems for Cell Therapy Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Automated Cell Processing Systems for Cell Therapy Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Automated Cell Processing Systems for Cell Therapy Market Value (USD Million) By Region

Table 10: Global Automated Cell Processing Systems for Cell Therapy Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Automated Cell Processing Systems for Cell Therapy Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Automated Cell Processing Systems for Cell Therapy Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Automated Cell Processing Systems for Cell Therapy Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cytiva Basic Information And Sales Area

Table 31: Cytiva. Products Portfolio

Table 32: Miltenyi Biotec Basic Information And Sales Area

Table 33: Miltenyi Biotec. Products Portfolio

Table 34: Thermo Fisher Scientific Basic Information And Sales Area

Table 35: Thermo Fisher Scientific. Products Portfolio

Table 36: Terumo Basic Information And Sales Area

Table 37: Terumo. Products Portfolio

Table 38: Merck Basic Information And Sales Area

Table 39: Merck. Products Portfolio

Table 40: Fresenius Kabi Basic Information And Sales Area

Table 41: Fresenius Kabi. Products Portfolio

Table 42: Sartorius Basic Information And Sales Area

Table 43: Sartorius. Products Portfolio

Table 44: Lonza Basic Information And Sales Area

Table 45: Lonza. Products Portfolio

Table 46: Boyalife (ThermoGenesis) Basic Information And Sales Area

Table 47: Boyalife (ThermoGenesis). Products Portfolio

Table 48: EurekaBio Basic Information And Sales Area

Table 49: EurekaBio. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Automated Cell Processing Systems for Cell Therapy Market Value (USD Million) By Region

Table 55: Global Automated Cell Processing Systems for Cell Therapy Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Automated Cell Processing Systems for Cell Therapy Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cytiva; Miltenyi Biotec; Thermo Fisher Scientific; Terumo; Merck; Fresenius Kabi; Sartorius; Lonza; Boyalife (ThermoGenesis); EurekaBio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Automated Cell Processing Systems for Cell Therapy Segmentation Breakdown6 items

Application

Academia

Industrial

Types

Stem Cell Therapy

Non-Stem Cell Therapy

Regional Insights

Loading chart…

Regional Key Drivers5 items

North America: policies, ecosystem maturity, demographics

Europe: infrastructure, ecosystem maturity, adoption

Asia Pacific: investments, demographics, policies

Latin America: increasing adoption, infrastructure development

Middle East & Africa: growing demographics, investments in healthcare

Competitive Landscape

Cytiva: regional expansion

Miltenyi Biotec: innovation pipeline

Thermo Fisher Scientific: vertical integration

Terumo: local manufacturing

Merck: premium pricing

Fresenius Kabi: OEM tie-ups

Key Automated Cell Processing Systems for Cell Therapy Companies10 items

Cytiva

Miltenyi Biotec

Thermo Fisher Scientific

Terumo

Merck

Fresenius Kabi

Sartorius

Lonza

Boyalife (ThermoGenesis)

EurekaBio

Market Ecosystem

Raw material/component suppliers — provide critical system components

OEMs / manufacturers — design and manufacture automated systems

Technology providers — develop underlying automation technologies

System integrators / EPCs — integrate systems for end-user applications

Distributors / channel partners — facilitate system sales and distribution

Regulators/standards bodies — establish guidelines and approvals

End users / buyers — adopt and utilize automated cell processing systems

Recent Industry Insights

Analyst Overview

Table of Contents